Helen of Troy HELE · NASDAQ
$28.89 -2.76% (-$0.82)
Summary
51 / 100 · Bulios Score
What speaks for it
- It earns 18 USD a year on every 100 USD of invested capital.
- It bought back its own shares for $103.2M in the last fiscal year, 15% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- Revenue fell by 5.0% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.2% a year over 5 years. Over the last 3 years it fell by 5.0% a year. Earnings per share fell by 16% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $99.2M.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 8
- Sell 0
Today's price within the analysts' price targets
The average target of $26.5 is 8.3% below today's price. 27% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Beauty & Wellness 52%
- Home & Outdoor 48%
By region
- UNITED STATES 72%
- EMEA 16%
- Asia Pacific 6.0%
- CANADA 4.1%
- Latin America 1.9%
Beauty & Wellness brings in 52% of revenue. Home & Outdoor grew fastest, by 1.5% a year.
Segments in detail